INFLUENZINUM
- Product NDC
- 0220-2619
- 11-digit product format
- 002202619
- Labeler code
- 0220
- Product ID
- 0220-2619_923a8aac-6e7a-77c3-e053-2a95a90a7cc4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED),INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- Dosage form
- PELLET
- Route
- ORAL
- Labeler
- Boiron
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2019-10-01
- Marketing end
- 0000-00-00
- Substance
- INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 12 [hp_C]/12[hp_C]; [hp_C]/12[hp_C]; [hp_C]/12[hp_C]; [hp_C]/12[hp_C]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record